Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165)
Le Querrec, A.; Derlon, A.; Deshayes, J.P.; Lefrançois, C.; Sillard, B.; Delassus, P.; Viel, J.F.; Kher, A.; Thomas, M.
Journal des Maladies Vasculaires 12 Suppl B: 99-101
1987
ISSN/ISBN: 0398-0499 PMID: 2834502 Document Number: 297548
Efficacy of a low molecular weight heparin (Kabi 2165) was compared with that of non-fractionated heparin in the prevention of abdominal surgery postoperative venous thrombosis by means of a double-blind randomized trial in 79 patients. Determination of D. dimers in these patients allowed assessment of specificity of this assay for detection of postoperative venous thrombosis.
Document emailed within 1 workday
Related Documents
Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609Wu, X.-x.; Chen, Y.; Tan, J.-p.; Liu, M.-l.; Zhang, J.-p. 2013: Modulation of low molecular weight heparin and heparin-binding epidermal growth factor on biological functions of human first trimester trophoblast Zhonghua Fu Chan Ke Za Zhi 48(2): 107-112
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Barrellier, M.T.; Le Hello, C.; Verfaille, M.; Vignon, C.; Bertin, T.; Boissel, M.; Dubois, F.; Fauchon, G.; Pegoix, M.; Thomassin, C.; Trahay, A.; Aubriot, J.H.; Vielpeau, C. 2000: Echo-doppler monitoring of asymptomatic distal deep vein thrombosis in patients given low-molecular-weight-heparin at prophylactic doses after orthopedic surgery Journal des Maladies Vasculaires 25(3): 195-200
Hassn, A.; Hassan, A.M. 1999: Treatment with low molecular weight heparin needs anticoagulation monitoring Journal of the American College of Surgeons 189(1): 141-142
Brieger, D.; Dawes, J. 1996: Long-term persistence of biological activity following administration of Enoxaparin sodium (clexane) is due to sequestration of antithrombin-binding low molecular weight fragments--comparison with unfractionated heparin Thrombosis and Haemostasis 75(5): 740-746
Katagiri, H.; Itoh, S.; Uchida, T.; Kawai, Y.; Watanabe, K. 1999: Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays Rinsho Byori. Japanese Journal of Clinical Pathology 47(11): 1046-1051
Paul, V.; Pudoor, A.; Earali, J.; John, B.; Anil Kumar, C.S.; Anthony, T. 2007: Trial of low molecular weight heparin in the treatment of viper bites Journal of the Association of Physicians of India 55: 338-342
Jacobsen, A.F.; Qvigstad, E.; Sandset, P.M. 2000: Treatment of venous thromboembolism in pregnancy with low molecular weight heparin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2448-2449
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Bannon, P.G.; Kim, M.J.; Dean, R.T.; Dawes, J. 1995: Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin Thrombosis and Haemostasis 73(4): 706-712
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Nesvold, A.; Ly, B.; Abildgaard, U.; Stiris, M. 1991: Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(27): 3296-3297
Nikolov, A.; Kovachev, I.; Petkov, I.; Dimitrov, A. 2000: Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics Akusherstvo i Ginekologiia 39(3): 35-40
2003: Low molecular weight heparin certoparin. Clear simplification of thrombosis treatment MMW Fortschritte der Medizin 145(19): Suppl. 1-3
Kaiser, B.; Hauptmann, J.; Markwardt, F. 1988: Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative Folia Haematologica 115(1-2): 119-125